Phosphatidylethanol and Other Ethanol Consumption Markers
The University of Texas Health Science Center at San Antonio · with National Institute on Alcohol Abuse and Alcoholism (NIAAA) · NCT06747364
Opens the official ClinicalTrials.gov record, with the study team’s contacts. Bored Studies doesn’t enroll anyone.
Key facts
- Compensation
- Not posted. Ask the study team before screening.
- Who can join
- Ages 21+ · All sexes
- Healthy volunteers
- Accepted
- Study type
- Interventional · Not applicable
- Target enrollment
- 80
- US sites recruiting
- 2
- Study start
- January 7, 2025
- Record last updated
- May 13, 2025
Status re-checked against ClinicalTrials.gov within the last 12 hours.
What the study is about
This study is intended to help the investigators understand how a biomarker found in the blood may be used to better identify the quantity and different patterns of alcohol use.
The investigators hope that the results of this study will help identify the uses of alcohol-use markers in the blood in future alcohol prevention and treatment programs. It is hoped that the information learned from this study will benefit other people in the future.
The study participants will come into the lab and will (1) consume alcohol in the lab designed to produce a peak blood alcohol concentration of 0.06% and have blood collected over 6 hours followed by abstinence for 10 days to give a small blood sample 4 times and (2) to give a small amount of blood 5 times within 28 days (naturalistic drinking) and provide answers about alcohol use.
Being studied: Alcohol (Ethanol)
Conditions: Healthy Volunteer; Alcohol Consumption
Eligibility criteria
Copied from the official record. The study team makes the final decision at screening.
Show full criteria
Inclusion Criteria
- are ≥ 21 years old;
- are height and weight proportionate (body mass index 18-30); and
- report drinking on > 1 days in the last month, with at least one day equal to at least achieving \~0.06% BAC.
Exclusion Criteria
- have significant current or predicted alcohol withdrawal symptoms (CIWA-AR scores ≥ 10);
- are currently in alcohol treatment;
- have substance use disorder (except nicotine, and/or caffeine);
- have a medical condition that would contraindicate participation (a positive urine pregnancy test, self-reported scheduled surgery or liver disease);
- are currently breast feeding;
- have a presence of a DSM-5 psychiatric disorder with symptoms of psychosis and/or delirium; or
- are unable to comprehend the informed consent process or study instructions.
Recruiting US locations
University of North Texas
Denton, TX 76201
Site contact: Donald Dougherty, PhD · 940-565-2649 · Donald.Dougherty@unt.edu
University of Texas Health Science Center San Antonio
San Antonio, TX 78229
Site contact: Nathalie Hill-Kapturczak, PhD · 210-567-2725 · hillkapturcz@uthscsa.edu
Study contacts (from the official record)
- Nathalie Hill-Kapturczak, PhD · 210-567-2725 · Hillkapturcz@uthscsa.edu
- Donald Dougherty, PhD · 940-565-2649 · Donald.Dougherty@unt.edu
Similar studies in Texas
All healthy volunteers studies in Texas →- RecruitingHealthy volunteersPhase 1Overnight stay mentioned
A Study of LY4355756 in Healthy Participants
Eli Lilly and Company
- Location
- Dallas, TX
- Eligibility basics
- Ages 18–65
- RecruitingHealthy volunteersPhase 1Overnight stay mentioned
A Phase I Study to Investigate the Pharmacokinetics and Safety of Capivasertib in Participants With Moderate Hepatic Impairment
AstraZeneca
- Location
- San Antonio, TX + 1 other US site
- Eligibility basics
- Ages 18–80
- RecruitingHealthy volunteersPhase 1Overnight stay mentioned
A Study of Eloralintide (LY3841136) in Participants With Obesity or Overweight
Eli Lilly and Company
- Location
- San Antonio, TX
- Eligibility basics
- Ages 18–65
- RecruitingHealthy volunteersPhase 1Overnight stay mentioned
Radiprodil in Participants With Hepatic Impairment
GRIN Therapeutics, Inc.
- Location
- DeSoto, TX + 1 other US site
- Eligibility basics
- Ages 18–75